Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Philadelphia medical technology company raises $37M, plans to hire ‘like crazy’

Proscia
By Author Proscia | June 14, 2022

David West, Proscia’s co-founder and CEO, said the funding will be used by the company to invest in product development, further scale its commercial operations, accelerate the adoption of computational pathology, and to expand its workforce.

The company currently has about 100 employees, West said, and it expects to add another 40 over the next six months.

Our website uses cookies. By using this site, you agree to its use of cookies.